Literature DB >> 27500860

Multifunctional PLGA/Parylene C Coating for Implant Materials: An Integral Approach for Biointerface Optimization.

M Golda-Cepa1, A Chorylek1, P Chytrosz1, M Brzychczy-Wloch2, J Jaworska3, J Kasperczyk3, M Hakkarainen4, K Engvall5, A Kotarba1.   

Abstract

Functionalizing implant surfaces is critical for improving their performance. An integrated approach was employed to develop a multifunctional implant coating based on oxygen plasma-modified parylene C and drug-loaded, biodegradable poly(dl-lactide-co-glycolide) (PLGA). The key functional attributes of the coating (i.e., anti-corrosion, biocompatible, anti-infection, and therapeutic) were thoroughly characterized at each fabrication step by spectroscopic, microscopic, and biologic methods and at different scales, ranging from molecular, through the nano- and microscales to the macroscopic scale. The chemistry of each layer was demonstrated separately, and their mutual affinity was shown to be indispensable for the development of versatile coatings for implant applications.

Entities:  

Keywords:  MG-63; PLGA; biointerface; coating; controlled drug elution; implant; oxygen plasma; parylene C

Mesh:

Substances:

Year:  2016        PMID: 27500860     DOI: 10.1021/acsami.6b08025

Source DB:  PubMed          Journal:  ACS Appl Mater Interfaces        ISSN: 1944-8244            Impact factor:   9.229


  2 in total

1.  CORR Insights®: Hyaluronic Acid-based Hydrogel Coating Does Not Affect Bone Apposition at the Implant Surface in a Rabbit Model.

Authors:  Ryan McLemore
Journal:  Clin Orthop Relat Res       Date:  2017-04-25       Impact factor: 4.176

2.  Molecular Characteristic, Antibiotic Resistance, and Detection of Highly Immunoreactive Proteins of Group B Streptococcus Strains Isolated From Urinary Tract Infections in Polish Adults.

Authors:  Anna Dobrut; Dorota Ochońska; Ewa Brzozowska; Sabina Górska; Jolanta Kaszuba-Zwoinska; Monika Gołda-Cępa; Andrzej Gamian; Monika Brzychczy-Wloch
Journal:  Front Microbiol       Date:  2022-03-22       Impact factor: 5.640

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.